NLRP3 and obesity disorder: Mechanistically, it has been proposed that lipid messengers (e.g., palmitate and ceramides), which are elevated in both individuals with obesity and HFD-challenged mice, act as signals for NLRP3 inflammasome priming and activation (125–129).